Digna Biotech, S.L. - Product Pipeline Review - 2016

  • ID: 3641064
  • Company Profile
  • 38 pages
  • Global Markets Direct
1 of 4
Digna Biotech, S.L. - Product Pipeline Review - 2016

Summary

‘Digna Biotech, S.L. - Product Pipeline Review - 2016’, provides an overview of the Digna Biotech, S.L.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Digna Biotech, S.L., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Digna Biotech, S.L.
- The report provides overview of Digna Biotech, S.L. including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Digna Biotech, S.L.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Digna Biotech, S.L.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Digna Biotech, S.L.’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Digna Biotech, S.L.
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Digna Biotech, S.L.’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Digna Biotech, S.L. Snapshot

Digna Biotech, S.L. Overview

Key Information

Key Facts

Digna Biotech, S.L. - Research and Development Overview

Key Therapeutic Areas

Digna Biotech, S.L. - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Digna Biotech, S.L. - Pipeline Products Glance

Digna Biotech, S.L. - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Digna Biotech, S.L. - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Digna Biotech, S.L. - Drug Profiles

Cardiotrophin-1

Product Description

Mechanism of Action

R&D Progress

disitertide

Product Description

Mechanism of Action

R&D Progress

Interferon Alfa-5

Product Description

Mechanism of Action

R&D Progress

DB-017

Product Description

Mechanism of Action

R&D Progress

DB-02901

Product Description

Mechanism of Action

R&D Progress

DB-036

Product Description

Mechanism of Action

R&D Progress

DB-039

Product Description

Mechanism of Action

R&D Progress

DB-055

Product Description

Mechanism of Action

R&D Progress

oncostatin M

Product Description

Mechanism of Action

R&D Progress

DB-027

Product Description

Mechanism of Action

R&D Progress

Digna Biotech, S.L. - Pipeline Analysis

Digna Biotech, S.L. - Pipeline Products by Target

Digna Biotech, S.L. - Pipeline Products by Route of Administration

Digna Biotech, S.L. - Pipeline Products by Molecule Type

Digna Biotech, S.L. - Pipeline Products by Mechanism of Action

Digna Biotech, S.L. - Recent Pipeline Updates

Digna Biotech, S.L. - Dormant Projects

Digna Biotech, S.L. - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Digna Biotech, S.L., Key Information

Digna Biotech, S.L., Key Facts

Digna Biotech, S.L. - Pipeline by Indication, 2016

Digna Biotech, S.L. - Pipeline by Stage of Development, 2016

Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016

Digna Biotech, S.L. - Partnered Products in Pipeline, 2016

Digna Biotech, S.L. - Partnered Products/ Combination Treatment Modalities, 2016

Digna Biotech, S.L. - Phase II, 2016

Digna Biotech, S.L. - Phase I, 2016

Digna Biotech, S.L. - Preclinical, 2016

Digna Biotech, S.L. - Discovery, 2016

Digna Biotech, S.L. - Pipeline by Target, 2016

Digna Biotech, S.L. - Pipeline by Route of Administration, 2016

Digna Biotech, S.L. - Pipeline by Molecule Type, 2016

Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016

Digna Biotech, S.L. - Recent Pipeline Updates, 2016

Digna Biotech, S.L. - Dormant Developmental Projects,2016

Digna Biotech, S.L., Other Locations

Digna Biotech, S.L., Subsidiaries

List of Figures

Digna Biotech, S.L. - Pipeline by Top 10 Indication, 2016

Digna Biotech, S.L. - Pipeline by Stage of Development, 2016

Digna Biotech, S.L. - Monotherapy Products in Pipeline, 2016

Digna Biotech, S.L. - Pipeline by Target, 2016

Digna Biotech, S.L. - Pipeline by Route of Administration, 2016

Digna Biotech, S.L. - Pipeline by Molecule Type, 2016

Digna Biotech, S.L. - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll